Moxolunic PD Ear Drop is a combination of Moxifloxacin (0.5%), a powerful antibiotic, and Prednisolone (1%), a corticosteroid. This combination is designed to treat bacterial infections in the ear while simultaneously reducing inflammation and pain. Moxifloxacin is effective against a broad spectrum of bacteria, inhibiting their ability to replicate, which helps clear ear infections caused by susceptible microorganisms. Prednisolone, as an anti-inflammatory agent, helps alleviate the swelling, redness, and discomfort often associated with ear infections, providing much-needed relief to patients.
Moxolunic PD is primarily indicated for treating bacterial infections of the outer and middle ear, such as acute otitis externa (swimmer's ear) and otitis media (middle ear infection). It is especially beneficial for patients who suffer from both infection and inflammation, as it provides a dual therapeutic effect. The drops are applied directly to the affected ear, ensuring targeted action and fast relief, without significant systemic side effects.
The combination of Moxifloxacin and Prednisolone offers an effective treatment option for both adults and children, under the guidance of a healthcare professional. Regular use can prevent the spread of infection and reduce the risk of complications, such as hearing loss or chronic ear conditions, that may arise from untreated ear infections.